Therapeutics for Ebola virus disease

Published by Daniel Youkee on Aug 18, 2022

View

Disclaimer

Sponsors

Contact

Abstract

Language

en

PICOS

PICO 70.1

Population
Patients with Ebola virus disease
Intervention
ZMapp
Comparator
Standard care
Outcomes

PICO 70.2

Population
Patients with Ebola virus disease
Intervention
mAb114
Comparator
Standard care
Outcomes

PICO 70.3

Population
Patients with Ebola virus disease
Intervention
Remdesivir
Comparator
Standard care
Outcomes

PICO 70.4

Population
Patients with Ebola virus disease
Intervention
REGN-EB3
Comparator
Standard care
Outcomes

PICO 70.5

Population
Patients with Ebola virus disease
Intervention
MAb114
Comparator
ZMapp
Outcomes

PICO 70.6

Population
Patients with Ebola virus disease
Intervention
REGN-EB3
Comparator
ZMapp
Outcomes

PICO 70.7

Population
Patients with Ebola virus disease
Intervention
ZMapp
Comparator
Remdesivir
Outcomes

PICO 70.8

Population
Patients with Ebola virus disease
Intervention
REGN-EB3
Comparator
mAb114
Outcomes

PICO 70.9

Population
Patients with Ebola virus disease
Intervention
mAb114
Comparator
Remdesivir
Outcomes

PICO 70.10

Population
Patients with Ebola virus disease
Intervention
REGN-EB3
Comparator
Remdesivir
Outcomes